These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18632973)

  • 21. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.
    Cook RF; Berger SL; Rushlow KE; McManus JM; Cook SJ; Harrold S; Raabe ML; Montelaro RC; Issel CJ
    J Virol; 1995 Mar; 69(3):1493-9. PubMed ID: 7853482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Envelope determinants of equine lentiviral vaccine protection.
    Craigo JK; Ezzelarab C; Cook SJ; Chong L; Horohov D; Issel CJ; Montelaro RC
    PLoS One; 2013; 8(6):e66093. PubMed ID: 23785473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment of a 293-cell line containing luciferase reporter for EIAV receptor and LTR functions].
    Wang DF; Zhang SQ; Ma XE; Jian ZJ; Zhou JH
    Wei Sheng Wu Xue Bao; 2007 Dec; 47(6):1070-5. PubMed ID: 18271266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.
    Li F; Chen C; Puffer BA; Montelaro RC
    J Virol; 2002 Feb; 76(4):1569-77. PubMed ID: 11799151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse.
    Pang H; Kong XG; Sentsui H; Kono Y; Sugiura T; Hasegawa A; Akashi H
    J Vet Med Sci; 1997 Dec; 59(12):1089-95. PubMed ID: 9450237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.
    Alexandersen S; Carpenter S
    J Virol; 1991 Aug; 65(8):4255-62. PubMed ID: 1649329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies.
    Liu C; Cook FR; Cook SJ; Craigo JK; Even DL; Issel CJ; Montelaro RC; Horohov DW
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):302-10. PubMed ID: 22795699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic reactivity of the major glycoprotein of equine infectious anemia virus, a retrovirus.
    Montelaro RC; West M; Issel CJ
    Virology; 1984 Jul; 136(2):368-74. PubMed ID: 6205503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and immunogenicity of equine infectious anemia virus membrane protein GP90].
    Dai CB; Xiao Y; Lu H; Shen RX; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):73-6. PubMed ID: 12870025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.
    Montelaro RC; Robey WG; West MD; Issel CJ; Fischinger PJ
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1711-7. PubMed ID: 2839603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.
    Tagmyer TL; Craigo JK; Cook SJ; Even DL; Issel CJ; Montelaro RC
    J Virol; 2008 Apr; 82(8):4052-63. PubMed ID: 18234792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain.
    Howe L; Craigo JK; Issel CJ; Montelaro RC
    J Gen Virol; 2005 Jan; 86(Pt 1):139-149. PubMed ID: 15604441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.
    Du J; Wang X; Ma J; Wang J; Qin Y; Zhu C; Liu F; Shao Y; Zhou J; Qiao W; Liu X
    Retrovirology; 2014 Mar; 11():26. PubMed ID: 24656154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.
    Connolly SA; Landsburg DJ; Carfi A; Wiley DC; Cohen GH; Eisenberg RJ
    J Virol; 2003 Jul; 77(14):8127-40. PubMed ID: 12829851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.
    Yin X; Hu Z; Gu Q; Wu X; Zheng YH; Wei P; Wang X
    J Virol; 2014 Jan; 88(2):1259-70. PubMed ID: 24227834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
    Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.